• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发患者和观察者报告的结局测量指标,以评估儿童和青少年的 COVID-19 体征和症状。

Development of patient- and observer-reported outcome measures to assess COVID-19 signs and symptoms in children and adolescents.

机构信息

RTI Health Solutions, Research Triangle Park, NC, USA.

Janssen Research and Development, Beerse, Belgium.

出版信息

J Patient Rep Outcomes. 2023 Jan 26;7(1):7. doi: 10.1186/s41687-023-00542-6.

DOI:10.1186/s41687-023-00542-6
PMID:36701073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9879250/
Abstract

BACKGROUND

The Symptoms of Infection with Coronavirus-19 (SIC) is a 30-item patient-reported outcome measure to evaluate the presence and severity of COVID-19 signs/symptoms in adults. This study expanded the context of use of the adult SIC among adolescents aged 12-17 years and supported a pediatric adaptation (the Pediatric SIC [PedSIC]) for caregiver assessment of signs/symptoms in children aged < 12 years.

METHODS

Draft versions of the PedSIC and reference materials containing sign/symptom definitions for adolescents, based on an assessment of the reading level of SIC items by a professional linguist, were developed to facilitate accurate completion of the SIC by adolescents and observer-report (PedSIC) by caregivers. For adolescents, reference materials were intended to provide definitions for selected signs/symptoms identified to have a higher reading level. Iterative rounds of cognitive debriefing interviews were conducted from November 2020 to January 2021 to evaluate adolescent understanding of the SIC reference materials and inform refinement of the PedSIC for caregivers of children too young to reliably self-report. Participants were identified via databases of individuals who previously expressed interest in participating in qualitative research and were then screened for eligibility. Recruitment quotas were established to improve sample diversity. Thematic analysis and descriptive statistics were used to assess qualitative and demographic data, respectively.

RESULTS

Nine healthy adolescents (mean [SD, range] age, 14 [1.76, 12-17] years, 56% female, 22% non-White; round 1, n = 6; round 2, n = 3) and 17 caregivers (mean [SD, range] age, 34 [6.28, 26-41] years, 59% female, 35% non-White; round 1, n = 9; round 2, n = 8) were interviewed. Adolescents understood the majority of signs/symptoms (22 of the 30 SIC items) without assistance or use of the reference materials during the cognitive debriefing interview. Definitions were added to the reference materials for 5 additional items, and clarifications provided to existing definitions for 3 items. Seven observer-report (PedSIC) items were modified following feedback from caregivers of healthy young children. Reference materials (similar to those for adolescent use) were developed to support caregiver understanding of the intent of the PedSIC items collecting input from children ages ≥ 5- < 12 years.

CONCLUSIONS

Results support using the SIC, PedSIC, and their associated reference materials to evaluate the presence and severity of COVID-19 signs/symptoms in adolescents and children aged < 12 years via caregiver-supported report, respectively.

摘要

背景

冠状病毒-19 症状(SIC)是一个 30 项的患者报告结局测量工具,用于评估成年人中 COVID-19 体征/症状的存在和严重程度。本研究扩展了成人 SIC 在 12-17 岁青少年中的使用范围,并支持了儿科适应(儿科 SIC [PedSIC]),用于评估<12 岁儿童的体征/症状。

方法

根据专业语言学家对 SIC 项目阅读水平的评估,制定了儿科 SIC 的草案版本和参考资料,其中包含了青少年体征/症状的定义,以方便青少年准确完成 SIC 和照顾者报告(儿科 SIC)。对于青少年,参考资料旨在为确定阅读水平较高的选定体征/症状提供定义。从 2020 年 11 月到 2021 年 1 月,进行了几轮认知访谈,以评估青少年对 SIC 参考资料的理解,并为照顾者报告(儿童太小而无法可靠地自我报告)的儿童的儿科 SIC 提供信息。通过对以前表示有兴趣参与定性研究的个人的数据库进行识别,参与者被确定,然后对其进行资格筛选。确定了招募配额,以提高样本多样性。使用主题分析和描述性统计分别评估定性和人口统计数据。

结果

共对 9 名健康青少年(平均[SD,范围]年龄 14 [1.76,12-17]岁,56%为女性,22%为非白人;第 1 轮 n=6;第 2 轮 n=3)和 17 名照顾者(平均[SD,范围]年龄 34 [6.28,26-41]岁,59%为女性,35%为非白人;第 1 轮 n=9;第 2 轮 n=8)进行了访谈。青少年在认知访谈中无需帮助或使用参考资料即可理解大多数体征/症状(30 项 SIC 项目中的 22 项)。参考资料中添加了 5 项其他项目的定义,并为 3 项现有定义提供了说明。根据健康幼儿照顾者的反馈,修改了 7 项观察者报告(儿科 SIC)项目。为了支持照顾者理解从 5-<12 岁儿童收集输入的儿科 SIC 项目的意图,制定了参考资料(与青少年使用的参考资料类似)。

结论

结果支持使用 SIC、儿科 SIC 及其相关参考资料,分别通过照顾者支持报告,评估青少年和<12 岁儿童的 COVID-19 体征/症状的存在和严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d863/9880111/7d22337b6e18/41687_2023_542_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d863/9880111/7d22337b6e18/41687_2023_542_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d863/9880111/7d22337b6e18/41687_2023_542_Fig1_HTML.jpg

相似文献

1
Development of patient- and observer-reported outcome measures to assess COVID-19 signs and symptoms in children and adolescents.开发患者和观察者报告的结局测量指标,以评估儿童和青少年的 COVID-19 体征和症状。
J Patient Rep Outcomes. 2023 Jan 26;7(1):7. doi: 10.1186/s41687-023-00542-6.
2
Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).评估儿童哮喘症状:支持开发儿童哮喘日记-患儿(PAD-C)和儿童哮喘日记-观察者(PAD-O)的定性研究。
J Patient Rep Outcomes. 2023 Oct 20;7(1):104. doi: 10.1186/s41687-023-00639-y.
3
Content validity of a novel patient-reported and observer-reported outcomes assessment to evaluate ocular symptoms associated with infectious conjunctivitis in both adult and pediatric populations.评估成人和儿童人群与传染性结膜炎相关的眼部症状的新型患者报告和观察者报告结局评估的内容效度。
Health Qual Life Outcomes. 2019 Oct 30;17(1):163. doi: 10.1186/s12955-019-1223-9.
4
Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial.《新型冠状病毒感染症状量表(SIC)的心理计量学评估:来自横断面研究和 3 期临床试验的结果》
J Patient Rep Outcomes. 2023 May 17;7(1):45. doi: 10.1186/s41687-023-00581-z.
5
Development and content validity testing of patient-reported outcome (PRO) items to assess chest congestion associated with the common cold for use in children and adolescents.用于评估儿童和青少年普通感冒相关胸部充血情况的患者报告结局(PRO)项目的开发及内容效度测试。
J Patient Rep Outcomes. 2022 May 28;6(1):56. doi: 10.1186/s41687-022-00465-8.
6
Measuring dengue illness intensity: Development and content validity of the dengue virus daily diary (DENV-DD).衡量登革热疾病严重程度:登革热病毒日常日记(DENV-DD)的制定和内容效度。
J Patient Rep Outcomes. 2023 Aug 23;7(1):84. doi: 10.1186/s41687-023-00624-5.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ).开发用于甲基丙二酸血症和丙酸血症(MMAPAQ)患者照顾者的症状和体征结局测量工具。
Mol Genet Metab. 2024 Sep-Oct;143(1-2):108577. doi: 10.1016/j.ymgme.2024.108577. Epub 2024 Sep 13.
9
Development and Content Validity Testing of Patient-Reported Outcome Items for Children to Self-Assess Symptoms of the Common Cold.儿童自评普通感冒症状的患者报告结局项目的开发和内容效度测试。
Patient. 2020 Apr;13(2):235-250. doi: 10.1007/s40271-019-00404-8.
10
Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.铁螯合疗法患者及照料者报告结局指标的定性改进与发展
Health Qual Life Outcomes. 2017 Jun 23;15(1):129. doi: 10.1186/s12955-017-0702-0.

本文引用的文献

1
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era.德尔塔(B.1.617.2)和奥密克戎(B.1.1.529)变异株流行时期儿童人群中 SARS-CoV-2 感染情况。
Virol J. 2022 Sep 8;19(1):144. doi: 10.1186/s12985-022-01873-4.
2
Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United States, March 1, 2020-January 31, 2022.儿童和青少年感染新冠病毒后的症状和情况 - 美国,2020 年 3 月 1 日-2022 年 1 月 31 日。
MMWR Morb Mortal Wkly Rep. 2022 Aug 5;71(31):993-999. doi: 10.15585/mmwr.mm7131a3.
3
Development of a novel patient-reported outcome measure to assess signs and symptoms of COVID-19.
开发一种新型患者报告结局指标以评估新型冠状病毒肺炎的体征和症状。
J Patient Rep Outcomes. 2022 Jul 29;6(1):85. doi: 10.1186/s41687-022-00471-w.
4
Hospitalizations of Children Aged 5-11 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022.5-11 岁儿童因实验室确诊 COVID-19 住院情况 - COVID-NET,14 个州,2020 年 3 月-2022 年 2 月。
MMWR Morb Mortal Wkly Rep. 2022 Apr 22;71(16):574-581. doi: 10.15585/mmwr.mm7116e1.
5
Acute Upper Airway Disease in Children With the Omicron (B.1.1.529) Variant of SARS-CoV-2-A Report From the US National COVID Cohort Collaborative.美国国家新冠队列协作组关于感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎(B.1.1.529)变异株儿童急性上呼吸道疾病的报告
JAMA Pediatr. 2022 Aug 1;176(8):819-821. doi: 10.1001/jamapediatrics.2022.1110.
6
Incidence Rates and Clinical Outcomes of SARS-CoV-2 Infection With the Omicron and Delta Variants in Children Younger Than 5 Years in the US.美国 5 岁以下儿童感染奥密克戎和德尔塔变异株的发病率和临床结局。
JAMA Pediatr. 2022 Aug 1;176(8):811-813. doi: 10.1001/jamapediatrics.2022.0945.
7
Long COVID in Children and Adolescents.儿童和青少年的长期新冠症状
Life (Basel). 2022 Feb 14;12(2):285. doi: 10.3390/life12020285.
8
Clinical aspects and presumed etiology of multisystem inflammatory syndrome in children (MIS-C): A review.儿童多系统炎症综合征(MIS-C)的临床特征及推测病因:综述
Clin Epidemiol Glob Health. 2022 Mar-Apr;14:100966. doi: 10.1016/j.cegh.2022.100966. Epub 2022 Feb 3.
9
Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021.2021 年 7-8 月,美国六家医院收治的<18 岁儿童和青少年 COVID-19 患者的特征和临床结局。
MMWR Morb Mortal Wkly Rep. 2021 Dec 31;70(5152):1766-1772. doi: 10.15585/mmwr.mm705152a3.
10
Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children.COVID-19 的临床特征及与西班牙儿童严重程度相关的危险因素
Eur J Pediatr. 2022 Mar;181(3):1105-1115. doi: 10.1007/s00431-021-04306-6. Epub 2021 Nov 5.